Weight Loss Medication News

This living topic explores the growing influence of weight loss medications, particularly GLP-1 receptor agonists, on obesity treatment and healthcare access. Key issues include the effectiveness of these drugs, the rising demand for both injectable and oral options, and the financial burden associated with monthly treatment costs, which can exceed $1,000. Articles examine the disparities in access to these medications, regional trends in usage, and the challenges posed by insurance coverage limitations. The topic also delves into concerns surrounding side effects, long-term efficacy, and the evolving landscape of prescription weight loss treatments.

Latest

New survey shows how GLP-1s are changing household budgets

From savings contributions to everyday spending, consumers are making room in their budgets for weight-loss medications

Aug. 21, 2026 By Kristen Dalli

58% of GLP-1 users consider their medication an essential or important healthcare expense, according to a new Trimi survey.

Nearly half of GLP-1 users say they would pause savings or retirement contributions rather than stop their treatment.

Cost remains a major barrier to starting GLP-1 treatment, with nearly half of survey respondents identifying affordability as their biggest obstacle.

For Americans already juggling housing, groceries, and other rising household expenses...

Read Article

2026

Weight Loss Medication News

New survey shows how GLP-1s are changing household budgets

From savings contributions to everyday spending, consumers are making room in their budgets for weight-loss medications

GLP-1 drugs may offer a surprising bone benefit

CVS expands weight-loss program with $29 online visits and new GLP-1 options

GLP-1 weight loss is changing how people shop

Semaglutide may keep calorie intake lower even as hunger returns

GLP-1 drugs are changing how teens and young adults treat obesity

Nearly 60% of Americans say they'd go into debt for weight-loss medication

Study finds rare eye condition may be slightly more common with GLP-1 medications

Getting a GLP-1 online is surprisingly easy, study finds

Study suggests tirzepatide may boost the body's calorie-burning

People taking GLP-1 drugs spend less on groceries, study finds

Recent study finds weight loss drugs may increase women’s chances of getting hired

Experimental GLP-1 pill shows promise for weight loss

The GLP-1 stigma isn't going away — but public opinion may be changing

Intermittent fasting may be easier than counting calories, study finds

Surgery or shots? Study finds bigger heart health gains with bariatric procedures

Amazon Pharmacy is offering consumers new ways to access Eli Lilly’s new GLP-1 pill

FDA approves Eli Lilly’s Foundayo pill for weight loss

Stopping GLP-1 drugs may undo heart benefits faster than expected, study finds

Novo Nordisk is slashing the price of its popular weight-loss drugs